Literature DB >> 29308690

Overexpression of a conserved HSP40 chaperone reduces toxicity of several neurodegenerative disease proteins.

Sei-Kyoung Park1, Fatih Arslan1, Vydehi Kanneganti1, Sami J Barmada2, Pravinkumar Purushothaman3, Subhash Chandra Verma3, Susan W Liebman1.   

Abstract

TDP-43 and FUS are DNA/RNA binding proteins associated with neuronal inclusions in amyotrophic lateral sclerosis (ALS) patients. Other neurodegenerative diseases are also characterized by neuronal protein aggregates, e.g. Huntington's disease, associated with polyglutamine (polyQ) expansions in the protein huntingtin. Here we discuss our recent paper establishing similarities between aggregates of TDP-43 that have short glutamine and asparagine (Q/N)-rich modules and are soluble in detergents, with those of polyQ and PIN4C that have large Q/N-rich domains and are detergent-insoluble. We also present new, similar data for FUS. Together, we show that like overexpression of polyQ or PIN4C, overexpression of FUS or TDP-43 causes inhibition of the ubiquitin proteasome system (UPS) and toxicity, both of which are mitigated by overexpression of the Hsp40 chaperone Sis1. Also, in all cases toxicity is enhanced by the [PIN+] prion. In addition, we show that the Sis1 mammalian homolog DNAJBI reduces toxicity arising from overexpressed FUS and TDP-43 respectively in human embryonic kidney cells and primary rodent neurons. The common properties of these proteins suggest that heterologous aggregates may enhance the toxicity of a variety of disease-related aggregating proteins, and further that chaperones and the UPS may be key therapeutic targets for diseases characterized by protein inclusions.

Entities:  

Keywords:  DNAJB1; FUS; Sis1; TDP-43; Ubiquitin Proteasome System (UPS); [PIN+]; amyotrophic lateral sclerosis; chaperone; yeast

Mesh:

Substances:

Year:  2018        PMID: 29308690      PMCID: PMC5871033          DOI: 10.1080/19336896.2017.1423185

Source DB:  PubMed          Journal:  Prion        ISSN: 1933-6896            Impact factor:   3.931


  35 in total

1.  Prion-like properties of pathological TDP-43 aggregates from diseased brains.

Authors:  Takashi Nonaka; Masami Masuda-Suzukake; Tetsuaki Arai; Yoko Hasegawa; Hiroyasu Akatsu; Tomokazu Obi; Mari Yoshida; Shigeo Murayama; David M A Mann; Haruhiko Akiyama; Masato Hasegawa
Journal:  Cell Rep       Date:  2013-07-03       Impact factor: 9.423

2.  Evaluating the role of the FUS/TLS-related gene EWSR1 in amyotrophic lateral sclerosis.

Authors:  Julien Couthouis; Michael P Hart; Renske Erion; Oliver D King; Zamia Diaz; Tadashi Nakaya; Fadia Ibrahim; Hyung-Jun Kim; Jelena Mojsilovic-Petrovic; Saarene Panossian; Cecilia E Kim; Edward C Frackelton; Jennifer A Solski; Kelly L Williams; Dana Clay-Falcone; Lauren Elman; Leo McCluskey; Robert Greene; Hakon Hakonarson; Robert G Kalb; Virginia M Y Lee; John Q Trojanowski; Garth A Nicholson; Ian P Blair; Nancy M Bonini; Vivianna M Van Deerlin; Zissimos Mourelatos; James Shorter; Aaron D Gitler
Journal:  Hum Mol Genet       Date:  2012-03-27       Impact factor: 6.150

3.  Multiple Gln/Asn-rich prion domains confer susceptibility to induction of the yeast [PSI(+)] prion.

Authors:  L Z Osherovich; J S Weissman
Journal:  Cell       Date:  2001-07-27       Impact factor: 41.582

4.  Effects of Q/N-rich, polyQ, and non-polyQ amyloids on the de novo formation of the [PSI+] prion in yeast and aggregation of Sup35 in vitro.

Authors:  Irina L Derkatch; Susan M Uptain; Tiago F Outeiro; Rajaraman Krishnan; Susan L Lindquist; Susan W Liebman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-23       Impact factor: 11.205

5.  Prion-promoted phosphorylation of heterologous amyloid is coupled with ubiquitin-proteasome system inhibition and toxicity.

Authors:  Zi Yang; David E Stone; Susan W Liebman
Journal:  Mol Microbiol       Date:  2014-08-05       Impact factor: 3.501

6.  Investigating the interactions of yeast prions: [SWI+], [PSI+], and [PIN+].

Authors:  Zhiqiang Du; Liming Li
Journal:  Genetics       Date:  2014-04-11       Impact factor: 4.562

7.  Functional links between Aβ toxicity, endocytic trafficking, and Alzheimer's disease risk factors in yeast.

Authors:  Sebastian Treusch; Shusei Hamamichi; Jessica L Goodman; Kent E S Matlack; Chee Yeun Chung; Valeriya Baru; Joshua M Shulman; Antonio Parrado; Brooke J Bevis; Julie S Valastyan; Haesun Han; Malin Lindhagen-Persson; Eric M Reiman; Denis A Evans; David A Bennett; Anders Olofsson; Philip L DeJager; Rudolph E Tanzi; Kim A Caldwell; Guy A Caldwell; Susan Lindquist
Journal:  Science       Date:  2011-10-27       Impact factor: 47.728

Review 8.  Model organisms reveal insight into human neurodegenerative disease: ataxin-2 intermediate-length polyglutamine expansions are a risk factor for ALS.

Authors:  Nancy M Bonini; Aaron D Gitler
Journal:  J Mol Neurosci       Date:  2011-06-10       Impact factor: 3.444

9.  Overexpression of the essential Sis1 chaperone reduces TDP-43 effects on toxicity and proteolysis.

Authors:  Sei-Kyoung Park; Joo Y Hong; Fatih Arslan; Vydehi Kanneganti; Basant Patel; Alex Tietsort; Elizabeth M H Tank; Xingli Li; Sami J Barmada; Susan W Liebman
Journal:  PLoS Genet       Date:  2017-05-22       Impact factor: 5.917

10.  Huntington toxicity in yeast model depends on polyglutamine aggregation mediated by a prion-like protein Rnq1.

Authors:  Anatoli B Meriin; Xiaoqian Zhang; Xiangwei He; Gary P Newnam; Yury O Chernoff; Michael Y Sherman
Journal:  J Cell Biol       Date:  2002-06-10       Impact factor: 10.539

View more
  11 in total

1.  Hsp40 proteins phase separate to chaperone the assembly and maintenance of membraneless organelles.

Authors:  Jinge Gu; Zhenying Liu; Shengnan Zhang; Yichen Li; Wencheng Xia; Chen Wang; Huaijiang Xiang; Zhijun Liu; Li Tan; Yanshan Fang; Cong Liu; Dan Li
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-23       Impact factor: 11.205

Review 2.  Application of yeast to studying amyloid and prion diseases.

Authors:  Yury O Chernoff; Anastasia V Grizel; Aleksandr A Rubel; Andrew A Zelinsky; Pavithra Chandramowlishwaran; Tatiana A Chernova
Journal:  Adv Genet       Date:  2020-05-04       Impact factor: 1.944

Review 3.  Disruption of RNA Metabolism in Neurological Diseases and Emerging Therapeutic Interventions.

Authors:  Julia K Nussbacher; Ricardos Tabet; Gene W Yeo; Clotilde Lagier-Tourenne
Journal:  Neuron       Date:  2019-04-17       Impact factor: 17.173

4.  TWEAKing the Hippocampus: The Effects of TWEAK on the Genomic Fabric of the Hippocampus in a Neuropsychiatric Lupus Mouse Model.

Authors:  Dumitru A Iacobas; Jing Wen; Sanda Iacobas; Chaim Putterman; Noa Schwartz
Journal:  Genes (Basel)       Date:  2021-07-29       Impact factor: 4.096

5.  Human DnaJB6 Antiamyloid Chaperone Protects Yeast from Polyglutamine Toxicity Separately from Spatial Segregation of Aggregates.

Authors:  Jyotsna Kumar; Neila L Kline; Daniel C Masison
Journal:  Mol Cell Biol       Date:  2018-11-13       Impact factor: 4.272

6.  Calcium-responsive transactivator (CREST) toxicity is rescued by loss of PBP1/ATXN2 function in a novel yeast proteinopathy model and in transgenic flies.

Authors:  Sangeun Park; Sei-Kyoung Park; Naruaki Watanabe; Tadafumi Hashimoto; Takeshi Iwatsubo; Tatyana A Shelkovnikova; Susan W Liebman
Journal:  PLoS Genet       Date:  2019-08-07       Impact factor: 6.020

Review 7.  Yeast as a Model to Unravel Mechanisms Behind FUS Toxicity in Amyotrophic Lateral Sclerosis.

Authors:  Michelle Lindström; Beidong Liu
Journal:  Front Mol Neurosci       Date:  2018-06-28       Impact factor: 5.639

8.  HSP90 Co-Chaperone, CacyBP/SIP, Protects α-Synuclein from Aggregation.

Authors:  Anastasiia Bohush; Anna Filipek
Journal:  Cells       Date:  2020-10-08       Impact factor: 6.600

9.  Serum proteomic analysis of novel predictive serum proteins for neurological prognosis following cardiac arrest.

Authors:  Shuang-Shuang Gu; Jin Li; Min Jiang; Yi Zhou; Bing Yang; Kehui Xie; Yun-Fei Jiang; Xin-Rui Jiang; Fei He; Jun Wang
Journal:  J Cell Mol Med       Date:  2020-12-18       Impact factor: 5.295

10.  The interplay between redox signalling and proteostasis in neurodegeneration: In vivo effects of a mitochondria-targeted antioxidant in Huntington's disease mice.

Authors:  Brígida R Pinho; Ana I Duarte; Paula M Canas; Paula I Moreira; Michael P Murphy; Jorge M A Oliveira
Journal:  Free Radic Biol Med       Date:  2019-11-18       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.